Digest Network Come funziona
Network
/
Società
St
Non verificato

Stoke Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

43 comunicati stampa

Guarda tutti i comunicati
05/12/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Fiere
Stoke Therapeutics and Biogen Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
01/12/2025
Scienza
Infanzia
Medicina - Varie
Biotecnologia
Salute
Vetrine/Shopping
Farmaceutica
Eventi
Fiere
Stoke Therapeutics and Biogen Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
18/11/2025
Finanza
Biotecnologia
Farmaceutica
Salute
Sanità
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
17/11/2025
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Stoke Therapeutics and Biogen Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
05/11/2025
Eventi
Web e Social Network
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Stoke Therapeutics to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
04/11/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Web e Social Network
Telefonia e Varie
Mercato azionario
Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
30/10/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
20/10/2025
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Ottica
Eventi
Stoke Therapeutics Presents Two-Year Natural History Data from Patients with Autosomal Dominant Optic Atrophy (ADOA)
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
16/10/2025
Salute
Biotecnologia
Sanità
Scienza
Farmaceutica
Finanza
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/10/2025
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Industria
Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
Fonte
Stoke Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0